Atlas Trials

A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.

Clinical trial NCT06319118 · COMPLETED

Trial details

NCT number
NCT06319118
Sponsor
Second Affiliated Hospital of Soochow University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Salivation in Parkinson's Disease
Start date
2023-10-01
Primary completion
2025-09-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.